BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) Stock Analysis
Biofil Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical and chemicals company. It produces APIs, formulations, and chemical products for healthcare and industrial buyers. Domestic distributors and institutional customers form its sales base. The company is listed on Indian stock exchanges and operates from India.
Healthcare › Drug Manufacturers - Specialty & Generic
₹32.60
-5.53% 1W | -23.40% 52W
Market Cap
53 CR
P/E Ratio
108.7
52W High
₹46.3
52W Low
₹25.6
Div. Yield
0%
Beta
0.6
50 DMA
₹32.6
200 DMA
₹33.1
Profit Margin
1.4%
Inst. Own.
0%
🛑 HIT RESISTANCE
🛑 HIT RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.43 | 17.37 | 5.03 | 15.20 | 8.44 | 2.41 | 14.20 | 8.35 | 6.43 | 13.54 | 0.86 | 7.57 | 12.35 |
| Expenses | 2.01 | 17.13 | 4.84 | 15.24 | 8.13 | 2.29 | 13.89 | 8.24 | 6.42 | 13.42 | 0.77 | 7.14 | 12.21 |
| Operating Profit | 0.42 | 0.24 | 0.19 | -0.04 | 0.31 | 0.12 | 0.31 | 0.11 | 0.01 | 0.12 | 0.09 | 0.43 | 0.14 |
| OPM % | 17.28% | 1.38% | 3.78% | -0.26% | 3.67% | 4.98% | 2.18% | 1.32% | 0.16% | 0.89% | 10.47% | 5.68% | 1.13% |
| Other Income | 0.02 | 0.03 | 0.03 | 0.41 | 0.03 | 0.02 | 0.02 | 0.24 | 2.83 | 0.06 | 0.08 | 0.11 | 0.06 |
| Interest | 0.01 | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.11 | 0.11 | 0.11 | 0.08 | 0.10 | 0.10 | 0.10 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Profit before tax | 0.32 | 0.15 | 0.11 | 0.27 | 0.23 | 0.03 | 0.22 | 0.26 | 2.76 | 0.11 | 0.10 | 0.47 | 0.13 |
| Tax % | 25.00% | 20.00% | 18.18% | 11.11% | 26.09% | 33.33% | 27.27% | 23.08% | 12.68% | 27.27% | 30.00% | 55.32% | 23.08% |
| Net Profit | 0.24 | 0.12 | 0.09 | 0.25 | 0.17 | 0.02 | 0.16 | 0.20 | 2.41 | 0.08 | 0.08 | 0.21 | 0.11 |
| EPS in Rs | 0.15 | 0.07 | 0.06 | 0.15 | 0.10 | 0.01 | 0.10 | 0.12 | 1.48 | 0.05 | 0.05 | 0.13 | 0.07 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.86 | 13.17 | 13.45 | 12.36 | 23.13 | 29.69 | 35.75 | 22.38 | 30.04 | 40.04 | 33.40 | 28.40 | 34.32 |
| Expenses | 5.12 | 12.30 | 10.84 | 11.43 | 22.11 | 27.87 | 34.15 | 21.05 | 28.88 | 39.23 | 32.55 | 27.75 | 33.54 |
| Operating Profit | 0.74 | 0.87 | 2.61 | 0.93 | 1.02 | 1.82 | 1.60 | 1.33 | 1.16 | 0.81 | 0.85 | 0.65 | 0.78 |
| OPM % | 12.63% | 6.61% | 19.41% | 7.52% | 4.41% | 6.13% | 4.48% | 5.94% | 3.86% | 2.02% | 2.54% | 2.29% | 2.27% |
| Other Income | 0.46 | 0.53 | 0.14 | 0.10 | 0.10 | 0.17 | 0.80 | 0.15 | 0.10 | 0.49 | 0.31 | 3.08 | 0.31 |
| Interest | 0.21 | 0.15 | 0.16 | 0.15 | 0.16 | 0.12 | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | 0.01 | 0.00 |
| Depreciation | 0.25 | 0.26 | 0.28 | 0.30 | 0.37 | 0.41 | 0.41 | 0.43 | 0.43 | 0.40 | 0.38 | 0.27 | 0.28 |
| Profit before tax | 0.74 | 0.99 | 2.31 | 0.58 | 0.59 | 1.46 | 1.92 | 1.01 | 0.79 | 0.86 | 0.74 | 3.45 | 0.81 |
| Tax % | 20.27% | 20.20% | 22.51% | 20.69% | 20.34% | 17.81% | 34.90% | 31.68% | 29.11% | 17.44% | 24.32% | 19.13% | |
| Net Profit | 0.59 | 0.78 | 1.79 | 0.47 | 0.48 | 1.21 | 1.24 | 0.70 | 0.56 | 0.71 | 0.56 | 2.79 | 0.48 |
| EPS in Rs | 0.36 | 0.48 | 1.10 | 0.29 | 0.29 | 0.74 | 0.76 | 0.43 | 0.34 | 0.44 | 0.34 | 1.71 | 0.30 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -2.0% | -5.0% | 8.0% |
Shareholding Pattern
Promoters46.82%
DIIs0.08%
Public53.10%
Promoters46.79%
DIIs0.08%
Public53.12%
Promoters46.79%
DIIs0.08%
Public53.13%
Promoters46.79%
DIIs0.08%
Public53.12%
Promoters46.79%
DIIs0.08%
Public53.13%
Promoters46.82%
DIIs0.08%
Public53.11%
Promoters46.82%
FIIs0.03%
DIIs0.08%
Public53.08%
Promoters46.82%
DIIs0.08%
Public53.11%
Promoters46.79%
DIIs0.08%
Public53.12%
Promoters46.79%
DIIs0.08%
Public53.13%
BIOFILCHEM
Holdings Analysis
Key strengths & risk signals
54
Overall
51
Fundamental
58
Technical
Risks (4)
LOW MARGIN! 1.4% profit margin - thin profits.
POOR YEAR! Stock declined 23.4% in the last year.
WEAK POSITION! Current price (32.6) is below both moving averages.
BEARISH TREND! 50-day average (32.6) is below 200-day average (33.1) - negative signal.
Strengths (4)
FAIRLY VALUED! PEG of 1.54 indicates reasonable valuation.
BULLISH SENTIMENT! In last 30 days: 14 up days, 15 down days. Avg volume on up days: 120,175 vs down days: 24,021. Ratio: 5.0x
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
NEUTRAL! RSI at 48.3 - balanced momentum.
Fundamental & Technical Analysis
54Overall
51Fundamental
58Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: -1.9% (DECLINING, 2/15). Profit CAGR: 70.7% (EXCELLENT, 15/15).
Profit Margin
2/10
LOW MARGIN! 1.4% profit margin - thin profits.
PEG Valuation
8/10
FAIRLY VALUED! PEG of 1.54 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 53.1% public ownership - higher volatility risk.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (32.6) is below 200-day average (33.1) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (32.6) is below both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
1/10
POOR YEAR! Stock declined 23.4% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 15 down days. Avg volume on up days: 120,175 vs down days: 24,021. Ratio: 5.0x
RSI
3/5
NEUTRAL! RSI at 48.3 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 33.8% of 52W range - weakness visible.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -5.5% (1 week), 2.7% (1 month), -10.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOFILCHEM | ₹32.60 | 108.7 | 1.4% | -1.9% | 70.7% | -23.4% | 54 | HIT RESISTANCE | -95.8% | -50.0% | +93.8% | +63.2% |
| MANGALAM | ₹32.60 | – | -16.5% | -14.3% | – | -54.4% | 44 | CONSOLIDATION | -44.9% | -43.3% | -0.2% | -15.2% |
| VIVIMEDLAB | ₹5.50 | – | -231.3% | -27.9% | – | +12.7% | 42 | BREAKDOWN | +2,526.8% | +786.1% | -53.1% | -25.0% |
| LASA | ₹5.90 | – | -253.8% | -42.1% | – | -50.5% | 40 | BREAKDOWN | -82.9% | -14.3% | -94.0% | -1,300.0% |
| ORTINGLOBE | ₹15.60 | – | – | -74.4% | – | +31.9% | 52 | APPROACHING SUPPORT | +50.0% | – | – | – |
| VAISHALI | ₹8.20 | – | 4.1% | 18.0% | -15.2% | -27.4% | 57 | CONSOLIDATION | – | +278.0% | – | -15.0% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -28.3% | 49 | CONSOLIDATION | -52.8% | +8.7% | +27.3% | +2.9% |
| ALPA | ₹59.50 | 29.2 | 3.8% | 4.3% | 6.1% | -37.0% | 46 | APPROACHING SUPPORT | -91.5% | -28.6% | +25.1% | -23.9% |
Data from TradeAlone · Updated daily
No news tagged for BIOFILCHEM yet.
